Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemical and Biological Agents represent a broad category of hazardous substances and pathogens rather than a specific molecular target like a receptor or enzyme. Chemical agents include toxic substances such as nerve agents (e.g., Sarin), blister agents (e.g., Sulfur mustard), and blood agents (e.g., Cyanide), which disrupt vital physiological processes like neurotransmission or cellular respiration (CDC, 2023; NIH, 2022). Biological agents consist of bacteria, viruses, or toxins—such as Bacillus anthracis or Botulinum toxin—that cause severe disease or death in humans (WHO, 2024). These agents are not therapeutic targets themselves; instead, they are the causative factors of injury or illness that medical countermeasures, such as antidotes and vaccines, are designed to treat or prevent. Because this term encompasses a heterogeneous group of threats and lacks a specific biological structure, it is considered an incorrect designation for a single drug target.
Mechanisms vary by specific agent; for example, nerve agents inhibit acetylcholinesterase, while biological toxins like ricin inhibit protein synthesis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemical and Biological Agents.